Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Premier Air Charter, Inc. (OTC PINK:PREM), (Premier Air Charter', 'Premier' 'the Company”), today announced the availability ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, TD ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...

Corner Therapeutics, an immunotherapy company pioneering novel approaches to cancer and infection, today announced that its Distinguished Scientist, Scientific Co-founder and Board Member, Professor ...

In 2023, there were an estimated 44 thousand total incident cases of kidney transplants across the 7MM, with the number ...

Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping of ...

TD Cowen analyst Tyler Van Buren initiated coverage of Soleno Therapeutics (SLNO) with a Buy rating and $110 price target The firm says Vykat XR ...

FDA approval of VYKAT XR for hyperphagia in Prader-Willi Syndrome marks a major milestone for Soleno Therapeutics.

The conference represents a unique collaboration between the Prader-Willi Syndrome Association | USA (PWSA | USA), the Foundation for Prader-Willi Research (FPWR), and the International Prader-Willi ...